<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>VIRT-VITE FORTE- pyridoxine hydrochloride, folic acid and cyanocobalamin tablet, coated </strong><br>Virtus Pharmaceuticals<br></p></div>
<h1>Virt-Vite Forte Tablets <br> Prescription Dietary Supplement</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="DLDE"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-1"></a><p></p>
<p class="First"><span class="Bold">Rx</span></p>
</div>
<div class="Section" data-sectionCode="69718-5">
<a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Virt-Vite Forte Tablets is an orally administered prescription dietary supplement specifically formulated for the dietary management of patients with unique nutritional needs requiring increased folate levels.</p>
<p>Virt-Vite Forte Tablets should be administered under the supervision of a licensed medical practitioner.</p>
<p>Each round coated beige tablet contains the following dietary ingredients:</p>
<table width="60%">
<col align="left" valign="middle" width="60%">
<col align="center" valign="middle" width="20%">
<col align="center" valign="middle" width="20%">
<thead>
<tr class="First"><th class="Lrule Rrule" align="left" colspan="3">Supplement Fact s</th></tr>
<tr class="Botrule"><th class="Lrule Rrule" align="left" colspan="3">Serving Size: 1 Tablet</th></tr>
<tr class="Last">
<th class="Lrule" align="left"></th>
<th align="center">Amount Per Serving</th>
<th class="Rrule" align="center">% Daily Value</th>
</tr>
</thead>
<tfoot><tr class="First Last"><td align="left" colspan="3" valign="top"><span class="Italics">**Daily Values not established for patients with unique nutritional needs who are in need of supplementation as directed by a licensed medical practitioner.</span></td></tr></tfoot>
<tbody>
<tr class="Botrule First">
<td class="Lrule" align="left">
<span class="Bold">Vitamin B<span class="Sub">6</span></span> (as Pyridoxine HCl)</td>
<td align="center">25 mg</td>
<td class="Rrule" align="center">1250%</td>
</tr>
<tr class="Botrule">
<td class="Lrule" align="left">
<span class="Bold">Folacin</span> (Vitamin B<span class="Sub">9</span> )</td>
<td align="center">2.5 mg</td>
<td class="Rrule" align="center">625%</td>
</tr>
<tr class="Last">
<td class="Lrule" align="left">
<span class="Bold">Vitamin B<span class="Sub">12</span></span> (as Cyanocobalamin)</td>
<td align="center">2 mg</td>
<td class="Rrule" align="center">33333%</td>
</tr>
</tbody>
</table>
<p><span class="Bold">Other Ingredients:</span> Dibasic Calcium Phosphate Dihydrate, Microcrystalline Cellulose Ph 101, Opadry II Beige 40L17427 (Titanium Dioxide, Polydextrose, HPMC 2910/Hypromellose 3 cP, HPMC 2910/Hypromellose 6 cP, Triacetin/Glycerol Tri-acetate, HPMC 2910/Hypromellose 50 cP, Macrogol/Peg 8000, FD&amp;C Yellow #6/Sunset Yellow Aluminum Lake, FD&amp;C Blue #2/Indigo Carmine Aluminum Lake, FD&amp;C Red #40/Allura Red Aluminum Lake), Croscarmellose Sodium, Opadry II Clear Y-19-7483 (HPMC 2910/Hypromellose 6 cP, Maltodextrin, HPMC 2910/Hypromellose 3 cP, Macrogol/Peg 400, HPMC 2910/Hypromellose 50 cP, Magnesium Stearate</p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-3"></a><p></p>
<h1>FOLATE MECHANISM OF ACTION</h1>
<p class="First">FOLATE is essential for the production of certain coenzymes in many metabolic systems such as purine and pyrimidine synthesis. It is also essential in the synthesis and maintenance of nucleoprotein in erythropoiesis. It also promotes white blood cell (WBC) and platelet production in folate-<span class="product-label-link" type="condition" conceptid="4280354" conceptname="Nutritional anemia">deficiency anemia</span>. Folate is associated with methylation and transformylation biochemistry.</p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-4"></a><p></p>
<h1>FOLATE REGULATION</h1>
<p class="First">The Federal Register Notices from 1971 to 1973 established that increased folate was proper therapy in <span class="product-label-link" type="condition" conceptid="435789" conceptname="Megaloblastic anemia">megaloblastic anemias</span> of tropical and <span class="product-label-link" type="condition" conceptid="194992" conceptname="Celiac disease">nontropical sprue</span>, nutritional origin, pregnancy, infancy and childhood<span class="Sup">4,5,6</span>. Folate metabolism can be affected by <span class="product-label-link" type="condition" conceptid="194993" conceptname="Intestinal malabsorption">malabsorption</span> issues which differ widely among population groups. The March 5, 1996 Federal Register Notice (61 FR 8760) states that "The agency concluded <span class="Bold Italics">that the scientific literature did not support the superiority of any one source of folate over others, and that the data were insufficient to provide a basis for stating that a specific amount of folate is more effective than another amount</span> [emphasis added]<span class="Sup">9,10</span>." The actual amount and source of folate require a licensed medical practitioner's supervision to achieve a satisfactory maintenance level, and may exceed the 0.8 mg UL. The Federal Register Notice of August 2, 1973 (38 FR 20750) specifically states that "dietary supplement preparations are available without a prescription (21 CFR 121.1134). <span class="Bold Italics">Levels higher than dietary supplement amounts are available only with a prescription. Oral preparations supplying more than 0.8 mg of folate per dosage unit would be restricted to prescription dispensing</span> and that a dietary supplement furnishing 0.8 mg could be prescribed when a maintenance level of 0.8 mg per day was indicated ... When clinical symptoms have subsided and the blood picture and/or CSF folate levels have become normal, a maintenance level should be used. Patients should be kept under close supervision and adjustment of the maintenance level made if relapse appears imminent. In the presence of <span class="product-label-link" type="condition" conceptid="4218106" conceptname="Alcoholism">alcoholism</span>, <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">hemolytic anemia</span>, anticonvulsant therapy, or chronic <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>, the maintenance level may need to be increased [emphasis added]<span class="Sup">7</span>." In the Letter Regarding Dietary Supplement Health Claim for Folic Acid, Vitamin B6, and Vitamin B<span class="Sub">12</span> and Vascular Disease (Docket No. 99P-3029) dated November 28, 2000, FDA wrote "... high intakes of folate may partially and temporarily correct <span class="product-label-link" type="condition" conceptid="432295" conceptname="Pernicious anemia">pernicious anemia</span> while the neurological damage of vitamin B<span class="Sub">12</span> deficiency progresses. IOM/NAS (1998) set the UL for all adults of 1 mg per day because of devastating and irreversible neurological consequences of vitamin B<span class="Sub">12</span> deficiency, the data suggesting that <span class="Bold Italics"><span class="product-label-link" type="condition" conceptid="432295" conceptname="Pernicious anemia">pernicious anemia</span> may develop at a younger age in some racial or ethnic groups, and the uncertainty about the extent of the occurrence of vitamin B<span class="Sub">12</span> deficiency in </span><span class="Bold Italics Underline">younger age groups</span> (IOM/NAS, 1998) [emphasis added]<span class="Sup">8</span>." Summary: This product is a dietary management product that - due to advanced folate levels, requires administration under the care of a licensed medical practitioner, and the most appropriate way to do that is to provide the product as prescription for pedigree reporting and safety monitoring. The ingredients, indication or claims of this product are not to be construed to be drug claims.</p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-5"></a><p></p>
<h1><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">ALLERGY</span> STATEMENT</h1>
<p class="First">This product has been manufactured in a facility that also manufactures products containing milk and soy. Individuals with allergic tendencies to these substances should use discretion.</p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-6"></a><p></p>
<h1>INTERACTIONS</h1>
<p class="First">Talk to your healthcare practitioner and/or pharmacist before taking or using any prescription or over-the-counter medicines or herbal/health supplements alongside <span class="Bold">this product</span>.</p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-7"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First"><span class="Bold">This product</span> is contraindicated in patients with a known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the components contained in this product. <span class="Bold">This product</span> is contraindicated for individuals with conditions for which any of the ingredients are contraindicated.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-8"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Caution is recommended in patients with a history of bipolar illness. Mood elevation is possible in this population.</p>
<p>Caution is also recommended in patients taking anticonvulsant medications as folate may interfere with anticonvulsant medication, and may lower <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span> threshold. Furthermore, it has been reported that anticonvulsant medications interfere with folate metabolism, but the exact action is unclear; therefore caution is recommended with patients in this therapeutic group.</p>
<p>Folinic acid may enhance the toxicity of fluorouracil. <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">Deaths</span> from severe <span class="product-label-link" type="condition" conceptid="4184503" conceptname="Enterocolitis">enterocolitis</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, and <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span> have been reported in elderly patients receiving weekly formyl-THF and fluorouracil. Concomitant <span class="product-label-link" type="condition" conceptid="4218497" conceptname="Granulocytopenic disorder">granulocytopenia</span> and <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> were present in some but not all of the patients. The concomitant use of formyl-THF with trimethoprim- sulfamethoxazole for the acute treatment of <span class="product-label-link" type="condition" conceptid="438350" conceptname="Pneumocystosis">Pneumocystis carinii pneumonia</span> in patients with <span class="product-label-link" type="condition" conceptid="439727" conceptname="Human immunodeficiency virus infection">HIV infection</span> was associated with increased rates of treatment failure and mortality in a placebo controlled study.<span class="Sup">13</span></p>
<p>Patients undergoing cancer treatment should consult their licensed medical practitioner for advice.</p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-9"></a><p></p>
<h1>CAUTION</h1>
<p class="First">Folate alone is improper therapy in the treatment of <span class="product-label-link" type="condition" conceptid="432295" conceptname="Pernicious anemia">pernicious anemia</span> and other <span class="product-label-link" type="condition" conceptid="435789" conceptname="Megaloblastic anemia">megaloblastic anemias</span> where vitamin B<span class="Sub">12</span> is deficient. Folate in doses above 0.1 mg daily may obscure <span class="product-label-link" type="condition" conceptid="432295" conceptname="Pernicious anemia">pernicious anemia</span> in that hematologic remission may occur while neurological manifestations progress.</p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-10"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Virt-Vite Forte Tablets is indicated for patients in need of dietary supplementation as determined by a licensed medical practitioner.</p>
<p>Virt-Vite Forte Tablets should be administered under the supervision of a licensed medical practitioner</p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-11"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergic reactions</span> have been reported following the use of oral and parenteral folate. Mild transient <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="135214" conceptname="Polycythemia vera">polycythemia vera</span>, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, transitory <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">exanthema</span> and the feeling of <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span> of the entire body has been associated with cobalamin. <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, transient <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span>, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">epigastric pain</span>, and <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span> have been associated with acetylcysteine.</p>
<p>Call your medical practitioner about side effects.</p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-12"></a><p></p>
<h1>PHARMACOLOGY</h1>
<div class="Section" data-sectionCode="69719-3">
<a name="section-12.1"></a><p></p>
<h2>FOLATE</h2>
<p class="First">Folates are best known for reducing the incidence of fetal <span class="product-label-link" type="condition" conceptid="4102400" conceptname="Neural tube defect">neural tube defects</span> (NTDs). NTDs are congenital malformations produced by failure of the neural tube to form and close properly during embryonic development.<span class="Sup">3</span> During the first four weeks of pregnancy - when many women do not even realize that they have conceived, adequate maternal folate intake is essential to reduce the risk of NTDs. As the postnatal period approaches there is increased demand again for folate regardless of lactation status. Folate is involved in transformylation and methylation metabolism as well as - indirectly, succinylation metabolism (through the "methyl trap" hypothesis). Folate plays a central role in the formation of nucleic acid precursors, such as thymidylic acid and purine nucleotides, which are essential for nucleic acid synthesis and cell division. IOM/NAS (1998) noted that the evidence for a protective effect from folate supplements is much stronger than that for food folate<span class="Sup">10</span>. Other dietary ingredients are added to folate as cofactors, coenzymes and co-metabolites; in studies by Czeizel and Dudas (1992) and Berry et al. (1999), factors other than folate intakes may affect the magnitude of risk reduction or participate in a co-protective effect with folate<span class="Sup">10</span>.</p>
<p><span class="Bold">KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-13"></a><p></p>
<h1>DRUG INTERACTIONS</h1>
<p class="First">Drugs which may interact with folate include:</p>
<ul class="Disc">
<li>Antiepileptic drugs (AED): The AED class including, but not limited to, phenytoin, carbamazepine, primidone, valproic acid, fosphenytoin, valproate, phenobarbital and lamotrigine have been shown to impair folate absorption and increase the metabolism of circulating folate.</li>
<li>Additionally, concurrent use of folic acid has been associated with enhanced phenytoin metabolism, lowering the level of the AED in the blood and allowing breakthrough <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span> to occur. Caution should be used when prescribing this product among patients who are receiving treatment with phenytoin and other anticonvulsants.</li>
<li>Capecitabine: Folinic acid (5-formyltetrahydrofolate) may increase the toxicity of Capecitabine.</li>
<li>Cholestyramine: Reduces folic acid absorption and reduces serum folate levels.</li>
<li>Colestipol: Reduces folic acid absorptin and reduces serum folate levels.</li>
<li>Cycloserine: Reduces folic acid absorption and reduces serum folate levels.</li>
<li>Dihydrofolate Reductase Inhibitors (DHFRI): DHFRIs block the conversion of folic acid to itsactive forms, and lower plasma and red blood cell folate levels. DHFRIs include aminopterin, methotrexate, pyrimethamine, triamterene, and trimethoprim.</li>
<li>Fluoxetine: Fluoxetine exerts a noncompetitive inhibition of the 5-methyltetrahydrofolate active transport in the intestine.</li>
<li>Isotretinoin: Reduced folate levels have occurred in some patients taking isotretinoin.</li>
<li>L-dopa, triamterene, colchicine, and trimethoprim may decrease plasma folate levels.</li>
<li>Nonsteroidal Anti-inflammatory Drugs (NSAIDs): NSAIDs have been shown to inhibit some folate dependent enzymes in laboratory experiments. NSAIDs include ibuprofen, naproxen, indomethacin and sulindac.</li>
<li>Oral Contraceptives: Serum folate levels may be depressed by oral contraceptive therapy.</li>
<li>Methylprednisolone: Reduced serum folate levels have been noted after treatment with methylprednisolone.</li>
<li>Pancreatic Enzymes: Reduced serum folate levels have occurred in some patients taking pancreatic extracts, such a pancreatin and pancrelipase.</li>
<li>Pentamidine: Reduced folate levels have been seen with prolonged intravenous pentamidine.</li>
<li>Pyrimethamine: High levels of folic acid may result in decreased serum levels of pyrimethamine.</li>
<li>Smoking and Alcohol: Reduced serum folate levels have been noted.</li>
<li>Sulfasalazine: Inhibits the absorption and metabolism of folic acid.</li>
<li>Metformin treatment in patients with type 2 <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span> decreases serum folate.</li>
<li>Warfarin can produce significant impairment in folate status after a 6-month therapy.</li>
<li>Folinic acid may enhance the toxicity of fluorouracil.</li>
<li>Concurrent administration of chloramphenicol and folinic acid in folate-deficient patients may result in antagonism of the haematopoietic response to folate.</li>
<li>Caution should be exercised with the concomitant use of folinic acid and trimethoprim-sulfamethoxazole for the acute treatment of <span class="product-label-link" type="condition" conceptid="438350" conceptname="Pneumocystosis">Pneumocystis carinii pneumonia</span> in patients with <span class="product-label-link" type="condition" conceptid="439727" conceptname="Human immunodeficiency virus infection">HIV infection</span> as it is associated with increased rates of treatment failure and mortality in a placebo controlled study.</li>
</ul>
<p>Drugs which may interact with vitamin B<span class="Sub">12</span> (Methylcobalamin):</p>
<ul class="Disc">
<li>Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic, and potassium chloride may decrease the absorption of vitamin B<span class="Sub">12</span>.</li>
<li>Nitrous oxide can produce a functional vitamin B<span class="Sub">12</span> deficiency.</li>
</ul>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-14"></a><p></p>
<h1>REFERENCES</h1>
<ol class="Arabic">
<li>Wu A, Chanarin I, Levi AJ. <span class="product-label-link" type="condition" conceptid="4248718" conceptname="Macrocytosis">Macrocytosis</span> of <span class="product-label-link" type="condition" conceptid="435243" conceptname="Alcohol dependence">chronic alcoholism</span>. The Lancet. 1974;1:829-31.</li>
<li>Hallert C, Tobiasson P, Walan A. Serum folate determinations in tracing adult coeliacs. Scand J Gastroenterol. 1981; 16:263-67.</li>
<li>De-Regil LM, Fernández Gaxiola AC, Dowswell T, et al. Effects and safety of periconceptional folate supplementation for preventing <span class="product-label-link" type="condition" conceptid="4029540" conceptname="Congenital anomaly">birth defects</span>. Cochrane Database Syst Rev. 2010 Oct 6; (10): CD007950.doi: 10.1002/14651858. CD007950.pub2.</li>
<li>Federal Register Notice of April 9, 1971 (36 FR 6843).</li>
<li>The Federal Register Notice of August 2, 1973 (38 FR 20750).</li>
<li>The Federal Register Notice of October 17, 1980 (45 FR 69044).</li>
<li>The Federal Register Notice of August 2, 1973 (38 FR 20750).</li>
<li>Letter Regarding Dietary Supplement Health Claim for FolicAcid, Vitamin B6, and Vitamin B<span class="Sub">12</span> and Vascular Disease (Docket No. 99P-3029). November 28, 2000.</li>
<li>The Federal Register Notice of March 5, 1996 (61 FR 8760).</li>
<li>Letter Regarding Dietary Supplement Health Claim for Folic Acid With Respect to <span class="product-label-link" type="condition" conceptid="4102400" conceptname="Neural tube defect">Neural Tube Defects</span> (Docket No. 91N-100H).October 10, 2000.</li>
<li>Code of Federal Regulations Title 21 Section 172.345.</li>
<li>Code of Federal Regulations Title 21 Section 101.9(j)(8).</li>
<li>Safrin S, Lee BL, Sande MA. Adjunctive folinic acid with trimethoprimsulfamethoxazole for <span class="product-label-link" type="condition" conceptid="438350" conceptname="Pneumocystosis">Pneumocystis carinii pneumonia</span> in AIDS patients is associated with an increased risk of therapeutic failure and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>. J Infect Dis. 1994 Oct;170(4):912-7.</li>
</ol>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-15"></a><p></p>
<h1>PREGNANCY and NURSING MOTHERS</h1>
<p class="First">Virt-Vite Forte Tablets is not intended for use as a prenatal/postnatal multivitamin for lactating and nonlactating mothers. This product contains B vitamins in reduced form. Talk with your medical practitioner before using if pregnant or lactating.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-16"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">One to two tablets daily or as directed by a licensed medical practitioner.</p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-17"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Virt-Vite Forte Tablets are round coated beige tablets debossed on one side with "V201", and are supplied in bottles of 90 tablets.</p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-18"></a><p></p>
<h1>STORAGE</h1>
<p class="First">Store at Controlled Room Temperature 15°-30° C (59°-86°F). [See USP]. Protect from light and moisture. Dispense in a tight, light-resistant container.</p>
</div>
<div class="Section" data-sectionCode="69719-3">
<a name="section-19"></a><p></p>
<p class="First"><span class="Bold">KEEP THIS OUT OF REACH OF CHILDREN</span>.</p>
<p>All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product.</p>
<p>Call your medical practitioner about side effects.</p>
<p>You may report side effects by calling 813-283-1344 or 1-888-848-3593.</p>
<p>Product Code: 76439-365-90</p>
<p>*This product is a prescription-folate with or without other dietary ingredients that - due to increased folate levels (AUG 2 1973 FR 20750), requires an Rx on the label because of increased risk associated with masking of B<span class="Sub">12</span> deficiency (<span class="product-label-link" type="condition" conceptid="432295" conceptname="Pernicious anemia">pernicious anemia</span>). Based on our assessment of the risk of obscuring <span class="product-label-link" type="condition" conceptid="432295" conceptname="Pernicious anemia">pernicious anemia</span>, this product requires licensed medical supervision, an Rx status, and a National Drug Code (NDC) - or similar product code, as required by pedigree reporting requirements and supply-chain control as well as - in some cases, for insurance-reimbursement applications.</p>
<p>This product may - under certain circumstances, be dispensed through a certified mail-order program so long as there is record of prescription AND confirmation that the patient is under licensed medical supervision. This product is not an Orange Book (OB) rated product, therefore all prescriptions using this product shall be pursuant to state statutes as applicable.</p>
<p><span class="Bold">Rx</span></p>
<p><span class="Bold">Manufactured for:</span><br>Virtus Pharmaceuticals, LLC<br>Tampa, FL. 33619<br><span class="Bold">MADE IN USA</span></p>
<p>PC0297-01<br>Rev. 12/14</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-20"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 90 Tablet Bottle Label</h1>
<p class="First"><span class="Bold">VIRTUS</span><br>PHARMACEUTICALS</p>
<p>76439<span class="Bold">-365-</span>90</p>
<p><span class="Bold">Virt-Vite Forte</span></p>
<p><span class="Bold">Prescription Vitamin B<span class="Sub">9</span>-Containing<br>Dietary Supplement</span></p>
<p><span class="Bold">Rx</span></p>
<p><span class="Bold">90 Tablets</span><br>Made in the USA</p>
<div class="Figure"><img alt="Principal Display Panel" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8751d1f4-7ed7-40ce-bc4d-bde94d96a859&amp;name=virt-vite-01.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>VIRT-VITE FORTE 		
					</strong><br><span class="contentTableReg">pyridoxine hydrochloride, folic acid, and cyanocobalamin tablet, coated</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">DIETARY SUPPLEMENT</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NHRIC:76439-365</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>PYRIDOXINE HYDROCHLORIDE</strong> (PYRIDOXINE) </td>
<td class="formItem">PYRIDOXINE HYDROCHLORIDE</td>
<td class="formItem">25 mg</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>FOLIC ACID</strong> (FOLIC ACID) </td>
<td class="formItem">FOLIC ACID</td>
<td class="formItem">2.5 mg</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>CYANOCOBALAMIN</strong> (CYANOCOBALAMIN) </td>
<td class="formItem">CYANOCOBALAMIN</td>
<td class="formItem">2 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Titanium Dioxide</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Polydextrose</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>TRIACETIN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C YELLOW NO. 6</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALUMINUM OXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C BLUE NO. 2</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>FD&amp;C RED NO. 40</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Croscarmellose Sodium</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Maltodextrin</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Magnesium Stearate</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">PINK</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">9mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">V201</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NHRIC:76439-365-90</td>
<td class="formItem">90  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">DIETARY SUPPLEMENT</td>
<td class="formItem"></td>
<td class="formItem">02/09/2015</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Virtus Pharmaceuticals
							(969483143)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 2/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>7fda8408-effd-433c-9fde-f74f689c33e3</div>
<div>Set id: 8751d1f4-7ed7-40ce-bc4d-bde94d96a859</div>
<div>Version: 1</div>
<div>Effective Time: 20150211</div>
</div>
</div> <div class="DistributorName">Virtus Pharmaceuticals</div></p>
</body></html>
